RBP7 and neoplasm: Together with evidence that SREBP1-driven lipid metabolic reprogramming fuels TNBC growth, angiogenesis, and immune escape [46], these observations support a model in which endothelial and luminal RBP7 constitute a protective lipid-regulatory hub at the tumor–vascular interface.